Axxess Pharma Inc. (AXXE) ~~~~~~~~~~~~~~~~~~~~~~~~~~
Axxess Pharma, Inc. (AXXE), through its wholly owned subsidiary, AllStar Health Brands Inc., recently announced “that it plans to offer a shareholder dividend for year end 2015” based on “the expected major increase in sales across its entire product line, along with new sales from the introduction of new products.” “2014 has been a launch year for Axxess Pharma and our TapouT-branded products,” said AXXE`s President, Dr. Daniel Bagi in a Dec. 2 press release. “Sales have begun, and we look forward to ramping up significantly as we move forward. As we enter into 2015 we expect to have our products offered at several big-box retail outlets, to go along with a massive increase in promotional efforts and visibility. We are extremely excited by our upcoming sales initiatives and marketing campaigns and expect these to translate very quickly into sales volume increases. We also expect to see a significant uptick in online sales with the launch of our traffic-directed websites: TapouTMuscleRecovery.com and TapouTMuscleExplosion.com.
“For all these reasons we strongly believe a dividend representing approximately 10% of our net profit, will be issued to our shareholders at the end of 2015. At this time we cannot guarantee that we will undertake such dividend but it is our intention.” To read the Dec. 2 press release in its entirety, visit: http://finance.yahoo.com/news/axxess-pharma-announces-plans-distribute-130000711.html Disclaimer:
This is a paid profile. Do not base any investment decision upon any of the materials found in this publication or on our Web site.
The information contained on our website or in any of our newsletters is for informational purposes only, and is not intended to be advice, nor a recommendation and/or guidance for investment decisions. In preparing our publications, we rely upon publicly available information including press releases which we believe to be reliable, but have not verified. We are engaged in the business of profiling companies for monetary compensation.
All direct and third party compensation received has been disclosed in our newsletter and/or our website in accordance with section 1 7 ( b ) of the Sec urities Ac t of 1 9 33.
Compensation: We expect to receive five thousand dollars from a third party, Galaxy, LLC, for a one-day e-mail campaign for Axxess Pharma, Inc. We were previously compensated a total of nineteen thousand dollars from a third party, Galaxy, LLC for profile coverage for Axxess Pharma, Inc., which has expired.
Forward this email